ABOUT PHARMA EXCIPIENTS

“The existing predicament has uncovered some structural weaknesses inside the EU’s medicines source chain along with a substantial dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides stated. She proposed that supply chain difficulties be dealt with in an EU pharmaceutical system envisioned for being launched by t